Elsevier Publishes New Edition of Three-Volume Handbook of Crystal Growth

Loading...
Loading...

WALTHAM, MA --(Marketwired - January 22, 2015) - Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the publication of the new edition of the three-volume Handbook of Crystal Growth edited by Dr. Tatau Nishinaga, Dr. Peter Rudolph and Dr. Tom Kuech.

These combined works of reference present the underlying scientific foundation of the multi-disciplinary field of crystal growth. This long-awaited update of a seminal work in the field covers important new topics such as organic crystallization, bio-crystallization, and industrial crystallization techniques, with an emphasis on nano-materials, solar cell materials and nitride semiconductors. Readership for the handbooks includes: scientists and engineers from academia and industry, such as crystal growers, physicists, chemists, engineers, bioengineers, solid state scientists, materials scientists and earth scientists.

In volume one, the handbook addresses the underlying scientific principles relevant to all the techniques of crystal growth, the fundamentals. The second volume is devoted to bulk transport effects and the influence of transport-limited growth on the stability of both isolated growth forms (such as the dendrite) and arrays, and on the cooperative effects which lead to pattern formation. Recent developments in the phase field method and its application to real systems are also described. Focused on techniques, volume three covers thin films and epitaxy.

The new volumes are:



-- Handbook of Crystal Growth, Volume 1: Fundamentals, 2nd Edition, edited
by Tatau Nishinaga
-- Handbook of Crystal Growth, Volume 2: Bulk Crystal Growth, 2nd Edition,
edited by Peter Rudolph
-- Handbook of Crystal Growth, Volume 3: Thin Films and Epitaxy, 2nd
Edition, edited by Tom Kuech



The books are available on the Elsevier Store and on ScienceDirect, Elsevier's full-text scientific database offering journal articles and book chapters from over 2,200 peer-reviewed journals and more than 25,000 book titles.

Notes for Editors
Review copies of the books are available to credentialed journalists upon request. Contact Michelle McMahon at m.mcmahon.1@elsevier.com or +1 781 663 2268.

About Elsevier
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions -- among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey -- and publishes over 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are (EURONEXT AMSTERDAM: REN), REL, RUK and ENL.


Image Available: http://www.marketwire.com/library/MwGo/2015/1/21/11G031011/Images/Handbook_of_Crystal_Growth_Vol1_Ch1_Fig1-473885662332.jpg

Image Available: http://www.marketwire.com/library/MwGo/2015/1/21/11G031011/Images/Handbook_of_Crystal_Growth_Vol2_Ch1_Fig13-617265212842.jpg

Image Available: http://www.marketwire.com/library/MwGo/2015/1/21/11G031011/Images/Handbook_of_Crystal_Growth_Vol3_Ch1_Fig22-553702818136.jpg


FOR FURTHER INFORMATION PLEASE CONTACT:

Media contact
Michelle McMahon
Publicity Manager, Science & Technology Books
Elsevier
+1 781 663 2268
m.mcmahon.1@elsevier.com

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: Press Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...